Oncternal Therapeutics

About:

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers.

Website: http://www.oncternal.com

Twitter/X: oncternal

Top Investors: Mesa Verde Venture Partners, Global Source Ventures

Description:

Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers. Their pipeline has recently expanded and now includes two clinical-stage products with common regulatory and development strategies. Oncternal Therapeutics cutting-edge scientific approach is focused on targets that are uniquely expressed within cancer cells, resulting in highly targeted new therapies. They also apply a variety of therapeutic strategies to address different medical challenges - from antibodies and antibody-drug conjugates (ADCs) to small molecules and chimeric antigen receptor T-cells (CAR-T).